DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Mars Flavanol Exercise and Cognitive Function Study

Not Applicable

Completed

Conditions: Cognitive Function

Interventions: Dietary Supplement: Flavanol containing food product
Dietary Supplement: Food product lacking flavanol
Behavioral: Wait list control
Behavioral: Aerobic training

First Posted Date: 2010-08-11

Last Posted Date: 2018-12-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 41

Registration Number: NCT01180127

A Study of Medication With or Without Psychotherapy for Complicated Grief

Phase 2

Completed

Conditions: Bereavement
Complicated Grief

Interventions: Drug: Citalopram
Other: Placebo
Behavioral: Complicated Grief Treatment

First Posted Date: 2010-08-11

Last Posted Date: 2017-01-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 395

Registration Number: NCT01179568

Locations: 🇺🇸
VASDHS / University of California San Diego, San Diego, California, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
New York State Psychiatric Institute, New York, New York, United States

and more 1 locations

Cognitive Benefits of Aerobic Exercise Across the Age Span

Not Applicable

Completed

Conditions: Cognitive Function

Interventions: Behavioral: aerobic training
Behavioral: stretching/toning

First Posted Date: 2010-08-11

Last Posted Date: 2018-08-17

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 305

Registration Number: NCT01179958

Locations: 🇺🇸
Richard Sloan, New York, New York, United States

Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa

Not Applicable

Completed

Conditions: Anorexia Nervosa

Interventions: Behavioral: Cognitive Remediation Therapy
Behavioral: Exposure Therapy for AN (AN-EX/RP)

First Posted Date: 2010-08-03

Last Posted Date: 2015-01-29

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 40

Registration Number: NCT01174602

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone

Phase 3

Completed

Conditions: Schizophrenia

Interventions: Drug: Cognitive Remediation

First Posted Date: 2010-08-02

Last Posted Date: 2017-04-11

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 120

Registration Number: NCT01173874

Locations: 🇺🇸
Medical College of Georgia, Augusta, Georgia, United States
🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
🇺🇸
Columbia University, New York, New York, United States

and more 13 locations

D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD

Not Applicable

Completed

Conditions: Obsessive Compulsive Disorder

Interventions: Drug: D-cycloserine
Behavioral: Exposure and Response Prevention (EX/RP)

First Posted Date: 2010-07-30

Last Posted Date: 2014-08-19

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 16

Registration Number: NCT01172873

Locations: 🇺🇸
New York State Psychiatric Institute/Columbia University, New York City, New York, United States

Examining Common Substrates of Eating and Alcohol Use Disorders

Completed

Conditions: Bulimia Nervosa
Alcohol Use Disorders

First Posted Date: 2010-07-29

Last Posted Date: 2014-08-21

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 61

Registration Number: NCT01172210

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa

Not Applicable

Completed

Conditions: Anorexia Nervosa

Interventions: Drug: Placebo
Drug: Olanzapine

First Posted Date: 2010-07-27

Last Posted Date: 2018-06-29

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 152

Registration Number: NCT01170117

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Weill Cornell Medical Center, White Plains, New York, United States
🇺🇸
New York State Psychiatric Institute, New York, New York, United States

and more 2 locations

Studying the Effects of Sibutramine on Eating Behavior

Phase 4

Terminated

Conditions: Obesity

Interventions: Drug: Sibutramine
Drug: Placebo

First Posted Date: 2010-07-27

Last Posted Date: 2017-08-30

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 14

Registration Number: NCT01170364

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Gabapentin for Abstinence Initiation in Alcohol Dependence

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Other: Placebo
Drug: Gabapentin

First Posted Date: 2010-06-10

Last Posted Date: 2019-04-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 40

Registration Number: NCT01141049

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇺🇸
Substance Treatment and Research Service (STARS), New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy